Risedronate Sodium Tablets 17.5mg “F” from Fuji Pharmaceutical features Risedronate sodium hydrate, a bisphosphonate indicated for the prevention and treatment of osteoporosis and Paget’s disease. It has a standard of 17.5mg per tablet and YJ code 3999019F2057.
Risedronate Sodium Tablets 17.5mg “F”
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →More with the same ingredient
